# Retinol Binding Protein 4 Protein in Alopecia Areata Treated With Barcitinib

> **NCT06545110** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **South Valley University** · enrollment: 120 (estimated)

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** Baricitinib Oral Tablet

## Key facts

- **NCT ID:** NCT06545110
- **Lead sponsor:** South Valley University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06545110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06545110, "Retinol Binding Protein 4 Protein in Alopecia Areata Treated With Barcitinib". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06545110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*